| Fasudil | IC50 | 400.0 [1] |
| Cyclohexanecarboxamide, 4-[(1R)-1-aminoethyl]-N-4-pyridinyl-, trans- | IC50 | 89.0 [1] |
| Cyclohexanecarboxamide, 4-[(1R)-1-aminoethyl]-N-4-pyridinyl-, trans- | Ki | 300.0 [1] |
| [3-[[4-(Aminomethyl)-1-(5-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidine-4-carbonyl]amino]phenyl] N,N-dimethylcarbamate | IC50 | 10.0 [1], 32.0 [2], 340.0 [3] |
| N-(4-(1H-Pyrazol-4-yl)phenyl)-3,4-dihydro-2H-chromene-3-carboxamide | IC50 | 2.0 [1], 25.0 [2] |
| (S)-2-Methyl-1-[(4-methyl-5-isoquinoline)sulfonyl]-homopiperazine | IC50 | 5.0 [1], 12.0 [2] |
| Ripasudil | IC50 | 3.8 [1], 19.0 [2], 197.0 [3] |
| Oxolan-2-ylmethyl 3-[2-(aminomethyl)-5-[(3-fluoropyridin-4-yl)carbamoyl]phenyl]benzoate | IC50 | 2.5 [1], 49.0 [2] |
| Staurosporine | IC50 | 7.8 [1], 9.0 [2] |
| N-(2-(4-Bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide | IC50 | 270.0 [1], 3630.78 [2] |
| Tofacitinib | IC50 | 3400.0 [1] |
| 5-Aminoindazole | IC50 | 119700.0 [1] |
| 1-(3-Hydroxybenzyl)-3-(4-(pyridin-4-yl)thiazol-2-yl)urea | IC50 | 6.0 [1] |
| 1-[(1S)-2-Hydroxy-1-phenylethyl]-3-(4-pyridin-4-ylphenyl)urea | IC50 | 100.0 [1] |
| N-[2-[2-(Dimethylamino)ethoxy]-4-(1H-pyrazol-4-YL)phenyl]-2,3-dihydro-1,4-benzodioxin-2-carboxamide | IC50 | 3.0 [1], 3.2 [2] |
| N-[4-(Pyridin-4-yl)-1,3-thiazol-2-yl]-2,3-dihydro-1,4-benzodioxine-2-carboxamide | IC50 | 0.56 [1], 7.2 [2] |
| CID 71283262 | IC50 | 1.0 [1], 4.1 [2] |
| 5-Bromo-N-(pyridin-4-yl)pyridine-3-carboxamide | IC50 | 357200.0 [1] |
| [2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethylimidazo[4,5-c]pyridin-7-yl]-[(3S)-3-aminopyrrolidin-1-yl]methanone | IC50 | 6.0 [1], 7.0 [2] |
| 1-Benzyl-3-(1H-indazol-5-yl)urea | IC50 | 5500.0 [1] |
| (2S,3S,4R,5R)-N-[6-[[(2R)-6-Amino-1-[[6-[[(2R)-1-[[(2R)-1-amino-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-6-oxohexyl]amino]-1-oxohexan-2-yl]amino]-6-oxohexyl]-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolane-2-carboxamide | IC50 | 162.18 [1], 977.24 [2] |
| Nicotinamide, N-(4-pyridyl)- | IC50 | 55900.0 [1] |
| 1-(3-Methoxybenzyl)-3-(4-(pyridin-4-yl)thiazol-2-yl)urea | IC50 | 11.0 [1], 14.0 [2] |
| 4-Amino-N-(4-chlorobenzyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidine-4-carboxamide | IC50 | 66.0 [1], 143.0 [2] |
| N-(7-Chloro-1-oxo-1,2-dihydroisoquinolin-6-yl)-2-(dimethylamino)-2-phenylacetamide | IC50 | 19.0 [1], 26.0 [2] |
| N-(7-Chloro-1-oxo-1,2-dihydroisoquinolin-6-yl)-2-(methylamino)-2-phenylacetamide | IC50 | 12.0 [1] |
| 2-Amino-N-(7-chloro-1-oxo-1,2-dihydroisoquinolin-6-yl)acetamide | IC50 | 120.0 [1] |
| N-(7-Chloro-1-oxo-1,2-dihydroisoquinolin-6-yl)piperidine-4-carboxamide | IC50 | 28.0 [1] |
| 2-(Chroman-3-yl)-6-(pyridin-4-yl)-1H-benzo[d]imidazole | IC50 | 2.0 [1], 6.0 [2] |
| 4-(2-(Chroman-3-yl)-1H-benzo[d]imidazol-6-yl)pyrimidin-2-amine | IC50 | 8.0 [1], 66.0 [2] |
| 4-(2-(6-Methoxychroman-3-yl)-1H-benzo[d]imidazol-6-yl)pyrimidin-2-amine | IC50 | 2.0 [1], 99.0 [2] |
| 3-[6-(2-Aminopyrimidin-4-yl)-1H-benzimidazol-2-yl]-N-benzyl-3,4-dihydro-2H-chromene-6-carboxamide | IC50 | 1.0 [1], 23.0 [2] |
| 3-Amino-N-isoquinolin-6-yl-2-phenylpropanamide | IC50 | 1.1 [1] |
| 3-Amino-N-isoquinolin-6-yl-2-phenylpropanamide | Ki | 0.8 [1] |
| 2-(4-(6-(Pyridin-4-yl)-3-(pyrrolidin-1-yl)pyrazin-2-yl)piperazin-1-yl)ethanol | IC50 | 39.0 [1], 78.0 [2] |
| CID 46864283 | IC50 | 1.0 [1], 51.0 [2] |
| 2-Amino-N-(7-chloro-1-oxo-1,2-dihydroisoquinolin-6-yl)-2-phenylacetamide | IC50 | 26.0 [1], 57.0 [2] |
| N-(7-Chloro-1-oxo-1,2-dihydroisoquinolin-6-yl)-1-methylpiperidine-4-carboxamide | IC50 | 31.0 [1] |
| (R)-N-(7-Chloro-1-oxo-1,2-dihydroisoquinolin-6-yl)pyrrolidine-3-carboxamide | IC50 | 67.0 [1] |
| N-[(3-Methoxyphenyl)methyl]-6-(1H-pyrazol-4-yl)-1H-indole-2-carboxamide | IC50 | 2.0 [1] |
| N-[(3-Methoxyphenyl)methyl]-6-(1H-pyrazol-4-yl)-1H-indole-3-carboxamide | IC50 | 1.0 [1] |
| N-[(3-Methoxyphenyl)methyl]-6-(1H-pyrazol-4-yl)-1H-pyrrolo[2,3-b]pyridine-2-carboxamide | IC50 | 2.0 [1] |
| N-[(3-Methoxyphenyl)methyl]-6-(1H-pyrazol-4-yl)-1H-pyrrolo[2,3-b]pyridine-3-carboxamide | IC50 | 2.0 [1] |
| 2-Amino-N-isoquinolin-6-yl-2-phenylacetamide | IC50 | 1.5 [1] |
| 2-Amino-N-isoquinolin-6-yl-2-phenylacetamide | Ki | 1.5 [1] |
| 1-Ethyl-1-[(3-methoxyphenyl)methyl]-3-[4-(1H-pyrazol-4-yl)phenyl]urea | IC50 | 1.0 [1] |
| 1-(2-Methoxyethyl)-1-[(3-methoxyphenyl)methyl]-3-[4-(1H-pyrazol-4-yl)phenyl]urea | IC50 | 16.98 [1], 17.0 [2] |
| 1-(2-Hydroxyethyl)-1-[(3-methoxyphenyl)methyl]-3-[4-(1H-pyrazol-4-yl)phenyl]urea | IC50 | 1.0 [1] |
| 1-[(3-Methoxyphenyl)methyl]-1-(2-morpholin-4-ylethyl)-3-[4-(1H-pyrazol-4-yl)phenyl]urea | IC50 | 13.0 [1] |
| 1-[3-(Dimethylamino)-1-phenylpropyl]-3-[4-(1H-pyrazol-4-yl)phenyl]urea | IC50 | 2.0 [1] |
| 1-Benzyl-3-[2-fluoro-4-(1H-pyrazol-4-yl)phenyl]-1-(2-hydroxyethyl)urea | IC50 | 14.0 [1] |
| 1-(3-Hydroxy-1-phenylpropyl)-3-[4-(1H-pyrazol-4-yl)phenyl]urea | IC50 | 1.0 [1] |
| 1-[2-(Dimethylamino)ethyl]-1-[(3-methoxyphenyl)methyl]-3-[4-(1H-pyrazol-4-yl)phenyl]urea | IC50 | 1.0 [1] |
| 1-(2-Hydroxy-1-phenylethyl)-3-[4-(1H-pyrazol-4-yl)phenyl]urea | IC50 | 2.0 [1] |
| 1-(Cyclohexylmethyl)-3-[4-(1H-pyrazol-4-yl)phenyl]urea | IC50 | 751.0 [1], 751.62 [2] |
| 1-[(3-Methoxyphenyl)methyl]-3-[4-(1H-pyrazol-4-yl)phenyl]-1-(3-pyrrolidin-1-ylpropyl)urea | IC50 | 5.0 [1] |
| 1-[(3-Methoxyphenyl)methyl]-1-propan-2-yl-3-[4-(1H-pyrazol-4-yl)phenyl]urea | IC50 | 3.0 [1] |
| 1-(2-Aminoethyl)-1-[(3-methoxyphenyl)methyl]-3-[4-(1H-pyrazol-4-yl)phenyl]urea | IC50 | 1.0 [1] |
| 1-Benzyl-1-(2-hydroxyethyl)-3-[4-(1H-pyrazol-4-yl)phenyl]urea | IC50 | 11.99 [1], 12.0 [2] |
| 1-[(3-Methoxyphenyl)methyl]-1-(2-piperidin-1-ylethyl)-3-[4-(1H-pyrazol-4-yl)phenyl]urea | IC50 | 5.0 [1] |
| 1-[1-(3-Fluorophenyl)-3-hydroxypropyl]-3-[4-(1H-pyrazol-4-yl)phenyl]urea | IC50 | 2.0 [1] |
| 1-Cyclopropyl-1-[(3-methoxyphenyl)methyl]-3-[4-(1H-pyrazol-4-yl)phenyl]urea | IC50 | 1.0 [1] |
| 1-[3-Hydroxy-1-(3-methoxyphenyl)propyl]-3-[4-(1H-pyrazol-4-yl)phenyl]urea | IC50 | 2.0 [1] |
| 1-[(3-Methoxyphenyl)methyl]-3-[4-(1H-pyrazol-4-yl)phenyl]-1-(2-pyrrolidin-1-ylethyl)urea | IC50 | 3.0 [1] |
| 1-[(3-Methoxyphenyl)methyl]-1-(3-morpholin-4-ylpropyl)-3-[4-(1H-pyrazol-4-yl)phenyl]urea | IC50 | 4.0 [1] |
| 1-[(3-Methoxyphenyl)methyl]-1-methyl-3-[4-(1H-pyrazol-4-yl)phenyl]urea | IC50 | 1.0 [1] |
| 1-[(3-Methoxyphenyl)methyl]-1-(3-piperidin-1-ylpropyl)-3-[4-(1H-pyrazol-4-yl)phenyl]urea | IC50 | 4.0 [1] |
| 1-(2-Phenylethyl)-3-[4-(1H-pyrazol-4-yl)phenyl]urea | IC50 | 88.0 [1] |
| 1-(3-Phenylpropyl)-3-[4-(1H-pyrazol-4-yl)phenyl]urea | IC50 | 1017.0 [1] |
| N-[4-(1H-Pyrazol-4-yl)phenyl]-3,4-dihydro-1H-isoquinoline-2-carboxamide | IC50 | 279.9 [1], 280.0 [2] |
| 1-[(2,3-Dimethoxyphenyl)methyl]-3-[4-(1H-pyrazol-4-yl)phenyl]urea | IC50 | 253.0 [1] |
| 1-[(2,4-Dimethoxyphenyl)methyl]-3-[4-(1H-pyrazol-4-yl)phenyl]urea | IC50 | 331.0 [1], 331.13 [2] |
| 1-[(2,5-Dimethoxyphenyl)methyl]-3-[4-(1H-pyrazol-4-yl)phenyl]urea | IC50 | 570.0 [1] |
| 1-[(2,6-Dimethoxyphenyl)methyl]-3-[4-(1H-pyrazol-4-yl)phenyl]urea | IC50 | 924.0 [1] |
| 1-[(3,4-Dimethoxyphenyl)methyl]-3-[4-(1H-pyrazol-4-yl)phenyl]urea | IC50 | 424.62 [1], 425.0 [2] |
| 1-[(3,5-Dimethoxyphenyl)methyl]-3-[4-(1H-pyrazol-4-yl)phenyl]urea | IC50 | 281.0 [1] |
| 1-[(3-Fluoro-4-methoxyphenyl)methyl]-3-[4-(1H-pyrazol-4-yl)phenyl]urea | IC50 | 357.0 [1] |
| 1-Ethyl-1-[(3-methoxyphenyl)methyl]-3-[2-[(3S)-1-methylpyrrolidin-3-yl]oxy-4-(1H-pyrazol-4-yl)phenyl]urea | IC50 | 1.0 [1] |
| 4-(Aminomethyl)-N-(3-fluoropyridin-4-yl)-3-[3-(phenylcarbamoyl)phenyl]benzamide | IC50 | 1.0 [1], 31.0 [2] |
| [(2S)-Butan-2-yl] 3-[[3-[2-(aminomethyl)-5-[(3-fluoropyridin-4-yl)carbamoyl]phenyl]benzoyl]amino]-4-fluorobenzoate | IC50 | 5.5 [1], 72.0 [2] |
| 2-Methoxyethyl 3-[[3-[2-(aminomethyl)-5-[(3-fluoropyridin-4-yl)carbamoyl]phenyl]phenyl]carbamoyl]-4-fluorobenzoate | IC50 | 1.0 [1], 2.2 [2] |
| Methyl 3-[[3-[2-(aminomethyl)-5-[(3-fluoropyridin-4-yl)carbamoyl]phenyl]benzoyl]amino]-2-fluorobenzoate | IC50 | 1.2 [1], 8.8 [2] |
| Cyclopentyl 3-[[3-[2-(aminomethyl)-5-[(3-fluoropyridin-4-yl)carbamoyl]phenyl]benzoyl]amino]-2-fluorobenzoate | IC50 | 1.4 [1], 41.0 [2] |
| N-[(2R)-1-[[(2R)-1-[[(2R)-1-[[(2R)-1-[[(2R)-1-[[(2R)-1-Amino-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]-6-[2-(isoquinolin-5-ylsulfonylamino)ethylamino]hexanamide | IC50 | 2.46 [1] |
| N-[3-(4-Dimethylaminomethyl-phenylcarbamoyl)-benzyl]-3,4-dimethoxy-benzamide | IC50 | 69.0 [1], 230.0 [2] |
| 3-Chloro-N-[3-(4-dimethylaminomethyl-phenylcarbamoyl)-benzyl]-4-methoxy-benzamide | IC50 | 92.0 [1], 230.0 [2] |
| N-[3-(4-Dimethylaminomethyl-phenylcarbamoyl)-benzyl]-4-methoxy-3-trifluoromethyl-benzamide | IC50 | 350.0 [1], 160000.0 [2] |
| N-[3-(4-Dimethylaminomethyl-phenylcarbamoyl)-benzyl]-4-methoxy-3-methyl-benzamide | IC50 | 660.0 [1], 266000.0 [2] |
| N-[3-(4-Dimethylaminomethyl-phenylcarbamoyl)-benzyl]-4-methoxy-benzamide | IC50 | 6500.0 [1], 1300000.0 [2] |
| 4-Cyano-N-[3-(4-dimethylaminomethyl-phenylcarbamoyl)-benzyl]-benzamide | IC50 | 6500.0 [1], 1700000.0 [2] |
| N-[3-(4-Dimethylaminomethyl-phenylcarbamoyl)-benzyl]-3-methoxy-benzamide | IC50 | 7000.0 [1], 7000000.0 [2] |
| 3-Chloro-N-[3-(4-dimethylaminomethyl-phenylcarbamoyl)-benzyl]-4-trifluoromethoxy-benzamide | IC50 | 1300.0 [1], 670000.0 [2] |
| 3-[3-(4-Cyano-phenyl)-ureidomethyl]-N-(1,2,3,4-tetrahydro-isoquinolin-7-yl)-benzamide | IC50 | 14.0 [1], 48.0 [2] |
| N-(4-Aminomethyl-phenyl)-3-[3-(4-cyano-phenyl)-ureidomethyl]-benzamide | IC50 | 210.0 [1], 70000.0 [2] |
| 3-[3-(4-Cyano-phenyl)-ureidomethyl]-N-(4-dimethylaminomethylphenyl)-benzamide | IC50 | 65.0 [1], 160.0 [2] |
| 3,4-Dimethoxy-N-[3-(2-piperidin-3-yl-ethylcarbamoyl)-benzyl]-benzamide | IC50 | 53.0 [1], 140.0 [2] |
| 3,4-Dimethoxy-N-[3-(1,2,3,4-tetrahydro-isoquinolin-6-ylcarbamoyl)-benzyl]-benzamide | IC50 | 320.0 [1], 100000.0 [2] |
| N-[4-(1H-Pyrazol-4-yl)phenyl]-2,3-dihydro-1,4-benzodioxine-2-carboxamide | IC50 | 2.0 [1], 72.0 [2] |
| N-(2-(2-(Dimethylamino)ethoxy)-4-(1H-pyrazol-4-yl)phenyl)chroman-3-carboxamide | IC50 | 3.0 [1], 6.0 [2] |
| 4-(2-(6-Methoxy-3,4-dihydro-2H-chromen-3-yl)benzo[d]oxazol-6-yl)pyrimidin-2-amine | IC50 | 2.0 [1], 46.0 [2] |